Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Atherosclerosis is a vascular pathology characterized by inflammation and plaque build-up within arterial vessel walls. Vessel occlusion, often occurring after plaque rupture, can result in myocardial and cerebral infarction. Epigenetic changes are increasingly being associated with atherosclerosis and are of interest from both therapeutic and biomarker perspectives. Emerging genomic approaches that profile DNA methylation, chromatin accessibility, post-translational histone modifications, transcription factor binding, and RNA expression in low or single cell populations are poised to enhance our spatiotemporal understanding of atherogenesis. Here, we review recent therapeutically relevant epigenetic discoveries and emerging technologies that may generate new opportunities for atherosclerosis research.

Original publication

DOI

10.1016/j.molmed.2017.02.004

Type

Journal article

Journal

Trends Mol Med

Publication Date

04/2017

Volume

23

Pages

332 - 347

Keywords

atherosclerosis, endothelial, epigenetics, inflammation, transcription, Animals, Atherosclerosis, DNA Methylation, Epigenesis, Genetic, Genomics, Histone Code, Humans, Inflammation, NF-kappa B, Protein Processing, Post-Translational, RNA, Long Noncoding